Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$151.70−3.16 (-2.04%)
Close on Nov 13, 2026Market cap $20.36BP/E –Yield –
Guardant Health total assets
Total assets on the balance sheet at the end of each period.
Guardant Health's total assets was $1.89B at Sep 30, 2026. For fiscal 2025 it was $2.01B, up 35.5% from the year before. The highest annual figure on record is $2.27B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.01B | +35.5% |
| FY2024 | Dec 31, 2024 | $1.49B | -16.8% |
| FY2023 | Dec 31, 2023 | $1.79B | +11.0% |
| FY2022 | Dec 31, 2022 | $1.61B | -27.0% |
| FY2021 | Dec 31, 2021 | $2.20B | -3.0% |
| FY2020 | Dec 31, 2020 | $2.27B | +136.0% |
| FY2019 | Dec 31, 2019 | $962.54M | +63.9% |
| FY2018 | Dec 31, 2018 | $587.40M | +71.3% |
| FY2017 | Dec 31, 2017 | $342.94M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.89B | +47.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.91B | +43.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.92B | +42.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.01B | +35.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.28B | -17.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.33B | -17.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.34B | -21.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.49B | -16.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.54B | -14.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.61B | -12.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.70B | +12.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.79B | +11.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.80B | +5.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.84B | -0.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.51B | -29.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.61B | -27.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.70B | -23.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.85B | -19.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.13B | -9.3% |
| Q4 FY2021 | Dec 31, 2021 | $2.20B | -3.0% |
| Q3 FY2021 | Sep 30, 2021 | $2.23B | +76.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.29B | +79.4% |
| Q1 FY2021 | Mar 31, 2021 | $2.35B | +147.5% |
| Q4 FY2020 | Dec 31, 2020 | $2.27B | +136.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.26B | +33.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.28B | +35.9% |
| Q1 FY2020 | Mar 31, 2020 | $948.17M | +63.7% |
| Q4 FY2019 | Dec 31, 2019 | $962.54M | +63.9% |
| Q3 FY2019 | Sep 30, 2019 | $948.33M | +175.2% |
| Q2 FY2019 | Jun 30, 2019 | $939.99M | +174.1% |
| Q1 FY2019 | Mar 31, 2019 | $579.17M | – |
| Q4 FY2018 | Dec 31, 2018 | $587.40M | – |
| Q3 FY2018 | Sep 30, 2018 | $344.60M | – |
| Q4 FY2017 | Dec 31, 2017 | $342.94M | – |
See a number that looks wrong?